947156-24-3

Basic information

• Product Name: 2-acetoxy-2-(3-chlorophenyl)acetic acid
• Synonyms: 2-acetoxy-2-(3-chlorophenyl)acetic acid
• CAS NO: 947156-24-3
• Molecular Weight: 228.632
• Mol File: 947156-24-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-acetoxy-2-(3-chlorophenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-acetoxy-2-(3-chlorophenyl)acetic acid(947156-24-3)
• EPA Substance Registry System: 2-acetoxy-2-(3-chlorophenyl)acetic acid(947156-24-3)

Safety Data

• Hazardous Substances Data: 947156-24-3(Hazardous Substances Data)

Usage

Classification

Non-steroidal anti-inflammatory drug (NSAID)

Medical Use

Analgesic and anti-inflammatory medication

Indications

Treatment of various forms of arthritis (osteoarthritis, rheumatoid arthritis), pain, and inflammatory conditions

Mechanism of Action

Inhibits synthesis of prostaglandins involved in inflammation and pain initiation

Cautionary Notes

Should be used under medical supervision
Potential adverse effects:
Gastrointestinal problems
Liver damage
Allergic reactions

Upstream product

• 16273-37-3 3-chloromandelic acid 
• 75-36-5 acetyl chloride 

Downstream Products

• 196106-48-6 (R)-2-acetoxy-2-(3'-chlorophenyl)acetic acid 
• 16273-37-3 (R)-3-chloromandelic acid 
• 16273-37-3 (S)-2-(3-chlorophenyl)-2-hydroxyacetic acid 

Relevant articles and documents

PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS

Provided herein are compounds of formula (I) as shown below, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.

PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS TO TREAT VIRAL INFECTIONS

Provided herein are methods for treating a viral infection in a patient, comprising administering to said patient a therapeutically effective amount of a PERK inhibitor selected from a compound having the structure (I):

MANDELIC HYDRAZIDES

Novel mandelic hydrazides of the formula (I), in which R1-R11 have the meanings indicated in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.